The Institut Pasteur de Lille was strongly represented at the GRC Tuberculosis Drug Discovery and Development conference in Barcelona, one of the leading conferences in the field.
Researchers from the Center for Infection and Immunity of Lille (CIIL) and the Drugs and Molecules for Living Systems unit joined the international Tuberculosis research community to share their recent advances in the search for new therapies against tuberculosis..
Left to righet : Amine Pochet, Yoel Dagan, Vien Quang Tri Ho, Ernesto Anoz Carbonell, Nicolas Willand, Arnaud Machelart, Alain Baulard, Axelle Grandé, Zainab Edoo, Oriane Rivière, Ruben C. Hartkoorn
Improving the treatment is more crucial than ever — not only because current therapies are long and come with significant side effects, but also because tuberculosis still causes 1.5 million deaths every year, and antibiotic resistance is on the rise. The week was filled with outstanding presentations that are shaping the future of TB treatment. Our teams’ work was highlighted through several oral and poster presentations, sparking engaging discussions. A fantastic week under the sun, marked by rich scientific exchanges and exciting new collaborations.
